Katherine MacLean, PhD. is the Director of the Psychedelic Education and Continuing Care Program and a trained research scientist with a long-standing interest in the brain and the science of well-being. At the University of California, Davis, Katherine was supported by a NSF research fellowship to study the effects of mindfulness on well-being and brain function. As a postdoctoral research fellow and faculty member at the Johns Hopkins University School of Medicine, she worked with Dr. Roland Griffiths and his team. Her research on psilocybin and personality change suggests that this class of medicines may play an important role in enhancing mental health, promoting emotional well-being, and creativity throughout the lifespan. Her current focus is the role of psychedelics and meditation in preparing individuals for end-of-life and healing trauma related to grief. Email: email@example.com
Ingmar Gorman, M.A. is the Administrative Director of the Psychedelic Education and Continuing Care Program and a doctoral student in Clinical Psychology at the New School for Social Research. He received clinical training at Beth Israel Hospital, South Beach Psychiatric Hospital, and Bellevue Hospital. He is currently training at the Columbia University Center for Psychoanalytic Training and Research. Ingmar conducts psychotherapy research in MDMA-assisted psychotherapy for PTSD at the Multidisciplinary Association for Psychedelic Studies (MAPS). His primary interests include psychotherapy variables in drug-assisted psychotherapy and integrative harm reduction psychotherapy. He is a board member of Horizons Media, Inc., a not for-profit educational charity and organizer of the Horizons Conference: Perspectives on Psychedelics. Email: firstname.lastname@example.org
Andrew Tatarsky, Ph.D., is a leader in the field of harm reduction psychotherapy. The founder and director of The Center for Optimal Living in New York City, where treatment and professional training is based on Integrative Harm Reduction Therapy (IHRP). He has specialized in the field of substance use treatment for 30 years working as a counselor, psychologist, program director, trainer, advocate and author. He has devoted his career to developing a comprehensive understanding of the broad spectrum of substance use problems and an integrative harm reduction psychotherapy approach to treating this spectrum.
Dr. Michael Benibgui is a senior clinical psychologist and founding member at the Center for Optimal Living and research scientist in the fields of substance abuse and the bio-psycho-social impacts of stress on mental/physical health. He has directed mental health and harm-reduction based drug treatment programs in NYC community based organizations. He also served as assistant project director of a federally-funded clinical trial aimed at moderating alcohol use at Columbia University Medical Center. Dr. Benibgui was an early member of NYU’s Psychedelic Research Group and consults with various festivals on safety protocols / emergency counseling for event participants who choose to partake in psychedelic substances. His integrative clinical approach weaves together psychodynamic, motivational, mindfulness, cognitive-behavioral, existential, and positive psychology techniques.
Jen Talley, Ph.D. is a clinical psychologist who specializes in the treatment of trauma and co-occurring substance misuse. Working from an integrative harm reduction framework, Dr. Talley’s approach is interactive and focuses on the development of practical skills to manage intense emotions, reduce self-judgment, and promote self-compassion. Mindfulness skills are integrated into an active exploration of the interrelationship between thoughts, feelings, physical sensations, and behaviors, along with their contribution to substance misuse and relationship issues. Dr. Talley is the Assistant Director of the Concentration in Mental Health and Substance Abuse Counseling at the New School for Social Research where she participates in the training and supervision of graduate students in psychology. Email: email@example.com